| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | - | 11.524 | 14.750 | 9.224 | 12.726 | 15.360 | 11.885 | 24.250 |
| Total Income - EUR | - | - | - | 11.524 | 14.750 | 9.224 | 12.726 | 15.360 | 11.885 | 24.250 |
| Total Expenses - EUR | - | - | - | 3.113 | 5.712 | 7.924 | 6.562 | 3.037 | 2.802 | 10.034 |
| Gross Profit/Loss - EUR | - | - | - | 8.411 | 9.038 | 1.300 | 6.164 | 12.323 | 9.083 | 14.215 |
| Net Profit/Loss - EUR | - | - | - | 8.066 | 8.596 | 1.023 | 5.783 | 11.862 | 7.630 | 11.941 |
| Employees | - | - | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Check the financial reports for the company - Neurokid Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | - | 156 | 0 | 0 | 0 | 0 | 0 | 0 |
| Current Assets | - | - | - | 13.110 | 31.735 | 30.883 | 32.987 | 42.420 | 48.918 | 62.020 |
| Inventories | - | - | - | 0 | 0 | 1.301 | 556 | 997 | 0 | 0 |
| Receivables | - | - | - | 423 | 6.322 | 12.160 | 16.197 | 9.771 | 36.932 | 40.046 |
| Cash | - | - | - | 12.687 | 25.413 | 17.422 | 16.234 | 31.651 | 11.986 | 21.975 |
| Shareholders Funds | - | - | - | 12.912 | 21.258 | 21.878 | 27.175 | 39.122 | 46.633 | 58.314 |
| Social Capital | - | - | - | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | - | - | - | 354 | 10.478 | 9.005 | 5.812 | 3.298 | 2.285 | 3.707 |
| Income in Advance | - | - | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8622 - 8622" | |||||||||
| CAEN Financial Year |
8690
|
|||||||||
Comments - Neurokid Srl